课题基金 / 基金详情

DRUGS AND AGING--DEMOGRAPHIC, CLINICAL, AND COST DATA

DRUGS AND AGING--DEMOGRAPHIC, CLINICAL, AND COST DATA
药物与衰老——人口统计、临床和成本数据
批准号:
6190122
负责人:
JEROME L AVORN
金额:
$8.48万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-30 至 2002-01-31

项目摘要

项目成果

JEROME L AVORN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人摘要):越来越多的关注集中在
英文摘要
DESCRIPTION (Applicant's abstract): Increasing attention has been focused in recent years on the central role of drug therapy in preventing and treating illness in those over age 65. This has led to growing demands for data on the utilization, effectiveness, and outcomes of prescription medications in geriatric patients. Now that coverage of medication expenses for the elderly has become a central topic of debate at both the federal and local levels there is even greater for comprehensive, up-to-date data on the patterns of outcomes and costs of drug therapy for patients over 65, to inform the accelerating public debate. This application proposes the systematic construction of a multi-purpose database which will describe the economic, demographic, and clinical aspects of drug use in the elderly in one very large and generalizable population. The work will draw on the project team's experience in geriatric medicine, pharmaco-epidemiology, and health services research to build a resource that will be well positioned to inform future research and debate in this increasingly important area. The project will perform secondary analyses of previously collected data from the Medicaid and Pharmacy Assistance for the Aged and Disabled (PAAD) programs of the state of New Jersey, linked to the complete paid claims files of the Medicare program (Parts A and B) for all participants in that program living in the state of New Jersey. In their raw form, such claims data do not allow for any systematic investigation of patterns of use or clinical events. However, the modest level of support requested in the current application will make it possible to transform such data into a relational database that can be queried on many levels, and will be capable of addressing a number of important issues in geriatric drug use
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.amjmed.2003.08.025
发表时间: 2003-12-15
期刊: AMERICAN JOURNAL OF MEDICINE
影响因子: 5.9
作者: [Solomon, DH, Schneeweiss, S, Avorn, J]
通讯作者: Avorn, J
Suboptimal antidepressant use in the elderly.
老年人抗抑郁药的使用不理想。
DOI: 10.1097/01.jcp.0000155819.67209.e5
发表时间: 2005
期刊: Journal of clinical psychopharmacology
影响因子: 2.9
作者: [Wang,PhilipS, Schneeweiss,Sebastian, Brookhart,MAlan, Glynn,RobertJ, Mogun,Helen, Patrick,AmandaR, Avorn,Jerry]
通讯作者: Avorn,Jerry
RISKY GERIATRIC BENZODIAZEPINE USE--PREDICTORS & TRENDS
  • 批准号:
    2488631
  • 项目类别:
  • 资助金额:
    $4.14万
  • 财政年份:
    1996
  • 负责人:
    JEROME L AVORN
  • 依托单位:
RISKY GERIATRIC BENZODIAZEPINE USE--PREDICTORS & TRENDS
  • 批准号:
    2517966
  • 项目类别:
  • 资助金额:
    $26.94万
  • 财政年份:
    1996
  • 负责人:
    JEROME L AVORN
  • 依托单位:
RISKY GERIATRIC BENZODIAZEPINE USE--PREDICTORS & TRENDS
  • 批准号:
    2013418
  • 项目类别:
  • 资助金额:
    $24.16万
  • 财政年份:
    1996
  • 负责人:
    JEROME L AVORN
  • 依托单位:
NEPHROLOGIST CARE AND OUTCOMES IN RENAL INSUFFICIENCY
  • 批准号:
    2546250
  • 项目类别:
  • 资助金额:
    $30.7万
  • 财政年份:
    1996
  • 负责人:
    JEROME L AVORN
  • 依托单位:
海外基金